XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration


XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here’s how the two stack up on risk, returns, and diversification.

By –

Leave a Reply

Your email address will not be published. Required fields are marked *